The restraining of tumor growth in nebivolol-treated mice resulted from a significant inhibition of cellular proliferation, as revealed by Ki67 staining (Fig. 5d), and an enhanced cell death, as revealed by the activation of caspase-3 (Fig. 5e). This evidence concerns the gene CASP3 and neoplasm.